Hiroo Koyama
- Organic Chemistry top 10%
- Synthesis and Catalytic Reactions 2
-
- Epigenetics and DNA Methylation 6
- Peroxisome Proliferator-Activated Receptors 4
- Metabolism, Diabetes, and Cancer 3
- Coenzyme Q10 studies and effects 2
-
- Heterotopic Ossification and Related Conditions 4
-
- Medical Imaging and Pathology Studies 3
-
- Bone health and treatments 2
- Co-authors
- Eric J. StonerDennis S. YamashitaRick DanheiserRichard G. BallGregory D. BergerMasaji OhnoMikako ShirouzuTeruki Honma
- Journals
- Journal of the American Chemical Society (1 paper)PLoS ONE (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroo Koyama
27 papers receiving 526 citations
Peers
Comparison fields: 5 of 70
- Organic Chemistry 235
- Biochemistry 35
- Molecular Biology 252
- Pharmacology 51
- Computational Theory and Mathematics 40
Countries citing papers authored by Hiroo Koyama
This map shows the geographic impact of Hiroo Koyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroo Koyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroo Koyama more than expected).
Fields of papers citing papers by Hiroo Koyama
This network shows the impact of papers produced by Hiroo Koyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroo Koyama. The network helps show where Hiroo Koyama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroo Koyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 6 | |
| 10 | 2020 | 29 | |
| 11 | 2019 | 5 | |
| 12 | 2019 | 64 | |
| 13 | 2019 | 12 | |
| 14 | 2017 | 8 | |
| 15 | 2017 | 9 | |
| 16 | 2005 | 15 | |
| 17 | 2003 | 18 | |
| 18 | 2003 | 34 | |
| 19 | 1987 | 37 | |
| 20 | 1985 | 7 |
About Hiroo Koyama
Hiroo Koyama is a scholar working on Molecular Biology, Nephrology and Rheumatology, having authored 28 papers that have together received 547 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Heterotopic Ossification and Related Conditions (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Medical Imaging and Pathology Studies (3 papers), Bone health and treatments (2 papers), Coenzyme Q10 studies and effects (2 papers) and Synthesis and Catalytic Reactions (2 papers). The work is most often cited by research in Organic Chemistry (235 citations), Biochemistry (35 citations) and Molecular Biology (252 citations). Hiroo Koyama has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Eric J. Stoner, Dennis S. Yamashita, Rick Danheiser, Richard G. Ball, Gregory D. Berger, Masaji Ohno, Mikako Shirouzu, Teruki Honma, Tatsuo Shioda and Shun‐ichi Sekine. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.